Lv41
490 积分 2024-09-06 加入
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
4小时前
待确认
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies
5小时前
待确认
Clinical progress of engineered cellular immunotherapies for autoimmunity
9小时前
已完结
Rheumatoid Arthritis — Common Origins, Divergent Mechanisms
1天前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
1天前
已完结
Erythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial
1个月前
已完结
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
2个月前
已完结
International uniform response criteria for multiple myeloma
5个月前
已完结
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
6个月前
已完结
Augmented Hyper-CVAD Based on Dose-Intensified Vincristine, Dexamethasone, and Asparaginase in Adult Acute Lymphoblastic Leukemia Salvage Therapy
10个月前
已完结
皖公网安备34019202002308
